Keywords: Glycosite Analysis, Glycoproteomics, Mass Spectrometry, Glycosite, Enrichment, De-glycosylation, Intact glycopeptides, Quantification, Collision-inducced dissociation (CID), Electron transfer dissociation (ETD), Multistage tandem MS (MSn), Post-translational modifications, Covalent modifications, Numerous Cellular Processes, Glycoproteins, Post Proteomic er, N-linked glycans, Sugar structure elucidation, Micro-heterogeneity, Coexisting non-glycoproteins/peptides, Mammalian lectins, Galectins, selectins, Chemo-enzymatic labeling, De-Glycosylation Methods, O-GlcNAc modifcation, Beta-elemination, Michael addition, Dithiothreitol, Multiple lectin-mediated, Hydrazide chemistry, Non-redundant glycoproteins, Subproteome, O-GlcNAc Site, Mucin-type O-Glycosites, Electron Capture Dissociation (ECD), Infrared multiphoton dissociation (IRMPD), ETD/ECD Assisted Glycosite, Labeling based Quantification, Label-free Quantification, Immuno-enriched, BAP= Biotin pentylamine, ESI=Electrospray ionization, CDK=Climatic droplet keratopathy, CSC=Cell surface capturing, CRC=Colorectal cancer
Current Proteomics
Title: Editorial:[Special Issue: Post-Translational Proteomics and its Application (Guest Editor: Qing-Yu He)]
Volume: 7 Issue: 3
Author(s): Qing-Yu He
Affiliation:
Keywords: Glycosite Analysis, Glycoproteomics, Mass Spectrometry, Glycosite, Enrichment, De-glycosylation, Intact glycopeptides, Quantification, Collision-inducced dissociation (CID), Electron transfer dissociation (ETD), Multistage tandem MS (MSn), Post-translational modifications, Covalent modifications, Numerous Cellular Processes, Glycoproteins, Post Proteomic er, N-linked glycans, Sugar structure elucidation, Micro-heterogeneity, Coexisting non-glycoproteins/peptides, Mammalian lectins, Galectins, selectins, Chemo-enzymatic labeling, De-Glycosylation Methods, O-GlcNAc modifcation, Beta-elemination, Michael addition, Dithiothreitol, Multiple lectin-mediated, Hydrazide chemistry, Non-redundant glycoproteins, Subproteome, O-GlcNAc Site, Mucin-type O-Glycosites, Electron Capture Dissociation (ECD), Infrared multiphoton dissociation (IRMPD), ETD/ECD Assisted Glycosite, Labeling based Quantification, Label-free Quantification, Immuno-enriched, BAP= Biotin pentylamine, ESI=Electrospray ionization, CDK=Climatic droplet keratopathy, CSC=Cell surface capturing, CRC=Colorectal cancer
Export Options
About this article
Cite this article as:
He Qing-Yu, Editorial:[Special Issue: Post-Translational Proteomics and its Application (Guest Editor: Qing-Yu He)], Current Proteomics 2010; 7 (3) . https://dx.doi.org/10.2174/157016410792928170
DOI https://dx.doi.org/10.2174/157016410792928170 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MIANN Models in Medicinal, Physical and Organic Chemistry
Current Topics in Medicinal Chemistry Mitochondrial Respiratory Complex I: Structure, Function and Implication in Human Diseases
Current Medicinal Chemistry Integrin αvβ3 Antagonists for Anti-Angiogenic Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Current Molecular Medicine New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy
Current Drug Targets Vitamin D and miRNAs in Cancer
Current Gene Therapy C. elegans Genetic Networks Predict Roles for O-GlcNAc Cycling in Key Signaling Pathways
Current Signal Transduction Therapy Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery The Osteopontin Tissue Level as a Breast Cancer Biomarker in Females After Mastectomy Measured by the Capillary Gel Electrophoresis Technique
Combinatorial Chemistry & High Throughput Screening Therapeutic and Diagnostic Applications of Nanoparticles
Current Drug Targets Recent Advances in the Development of Casein Kinase 1 Inhibitors
Current Medicinal Chemistry Cyclooxygenase-2 Biology
Current Pharmaceutical Design Denosumab: The Era of Targeted Therapies in Bone Metastatic Diseases
Current Cancer Drug Targets Nanoparticles: Functionalization and Multifunctional Applications in Biomedical Sciences
Current Medicinal Chemistry HIF-1α Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms
Mini-Reviews in Medicinal Chemistry PPARδ Signaling Regulates Colorectal Cancer
Current Pharmaceutical Design Topoisomerase I-DNA Complex Stability Induced by Camptothecins and Its Role in Drug Activity&#
Current Medicinal Chemistry - Anti-Cancer Agents Thiopurine Immunomodulators in Ulcerative Colitis: Moving Forward with Current Evidence
Current Drug Targets CETUXIMAB: From Bench to Bedside
Current Cancer Drug Targets Immune Responses to Fungal Infections and Therapeutic Implications
Current Drug Targets - Immune, Endocrine & Metabolic Disorders